Structure

Physi-Chem Properties

Molecular Weight:  616.38
Volume:  681.171
LogP:  8.809
LogD:  5.856
LogS:  -4.591
# Rotatable Bonds:  12
TPSA:  97.74
# H-Bond Aceptor:  6
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.143
Synthetic Accessibility Score:  5.704
Fsp3:  0.538
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  2
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.928
MDCK Permeability:  1.349659578409046e-05
Pgp-inhibitor:  0.293
Pgp-substrate:  0.906
Human Intestinal Absorption (HIA):  0.085
20% Bioavailability (F20%):  0.993
30% Bioavailability (F30%):  0.898

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.032
Plasma Protein Binding (PPB):  96.10872650146484%
Volume Distribution (VD):  2.343
Pgp-substrate:  7.203346252441406%

ADMET: Metabolism

CYP1A2-inhibitor:  0.025
CYP1A2-substrate:  0.41
CYP2C19-inhibitor:  0.798
CYP2C19-substrate:  0.789
CYP2C9-inhibitor:  0.835
CYP2C9-substrate:  0.92
CYP2D6-inhibitor:  0.486
CYP2D6-substrate:  0.05
CYP3A4-inhibitor:  0.93
CYP3A4-substrate:  0.88

ADMET: Excretion

Clearance (CL):  14.264
Half-life (T1/2):  0.058

ADMET: Toxicity

hERG Blockers:  0.004
Human Hepatotoxicity (H-HT):  0.772
Drug-inuced Liver Injury (DILI):  0.931
AMES Toxicity:  0.019
Rat Oral Acute Toxicity:  0.883
Maximum Recommended Daily Dose:  0.85
Skin Sensitization:  0.039
Carcinogencity:  0.524
Eye Corrosion:  0.073
Eye Irritation:  0.151
Respiratory Toxicity:  0.983

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC237441

Natural Product ID:  NPC237441
Common Name*:   IRGODUUTQDWGCW-OXWAJMPISA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  IRGODUUTQDWGCW-OXWAJMPISA-N
Standard InCHI:  InChI=1S/C39H52O6/c1-23(2)12-14-28(26(7)8)21-38-22-29(16-13-24(3)4)37(9,10)39(36(38)44,19-18-25(5)6)35(43)32(34(38)42)33(41)27-15-17-30(40)31(20-27)45-11/h12-13,15,17-18,20,28-29,40,42H,7,14,16,19,21-22H2,1-6,8-11H3/t28-,29+,38+,39-/m0/s1
SMILES:  CC(=CC[C@@H](C[C@@]12C[C@@H](CC=C(C)C)C(C)(C)[C@@](CC=C(C)C)(C(=O)C(=C1O)C(=O)c1ccc(c(c1)OC)O)C2=O)C(=C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL505686
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001549] Monoterpenoids
          • [CHEMONTID:0001564] Bicyclic monoterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33514 garcinia assigu Species Clusiaceae Eukaryota n.a. n.a. n.a. PMID[12608850]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT80 Cell Line Raji Homo sapiens Activity = 60.0 % PMID[533006]
NPT80 Cell Line Raji Homo sapiens Activity > 80.0 % PMID[533006]
NPT2 Others Unspecified Activity = 19.7 % PMID[533006]
NPT2 Others Unspecified Activity = 54.9 % PMID[533006]
NPT2 Others Unspecified Activity = 88.1 % PMID[533006]
NPT2 Others Unspecified Activity = 100.0 % PMID[533006]
NPT1 Others Radical scavenging activity IC50 > 100000.0 nM PMID[533006]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC237441 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9726 High Similarity NPC305710
0.9252 High Similarity NPC46549
0.9252 High Similarity NPC264229
0.9225 High Similarity NPC42384
0.9225 High Similarity NPC477849
0.9225 High Similarity NPC157284
0.9225 High Similarity NPC23667
0.9225 High Similarity NPC473779
0.9225 High Similarity NPC473479
0.9225 High Similarity NPC289358
0.9225 High Similarity NPC50615
0.9225 High Similarity NPC165191
0.9225 High Similarity NPC297797
0.9225 High Similarity NPC46242
0.9225 High Similarity NPC245760
0.9225 High Similarity NPC114333
0.9225 High Similarity NPC51531
0.9225 High Similarity NPC5014
0.9225 High Similarity NPC469857
0.9225 High Similarity NPC28592
0.9225 High Similarity NPC149773
0.9225 High Similarity NPC91887
0.9161 High Similarity NPC294330
0.9122 High Similarity NPC132810
0.9116 High Similarity NPC471970
0.911 High Similarity NPC294679
0.911 High Similarity NPC469375
0.911 High Similarity NPC8493
0.911 High Similarity NPC145301
0.911 High Similarity NPC144247
0.9103 High Similarity NPC471972
0.9103 High Similarity NPC229218
0.9103 High Similarity NPC141817
0.9103 High Similarity NPC469855
0.9103 High Similarity NPC176030
0.9103 High Similarity NPC192597
0.9103 High Similarity NPC30846
0.9103 High Similarity NPC169214
0.9103 High Similarity NPC471971
0.9097 High Similarity NPC473527
0.9085 High Similarity NPC7464
0.9054 High Similarity NPC52692
0.8986 High Similarity NPC273798
0.898 High Similarity NPC469854
0.898 High Similarity NPC469856
0.8912 High Similarity NPC209085
0.8912 High Similarity NPC224884
0.8851 High Similarity NPC309169
0.8851 High Similarity NPC196941
0.8828 High Similarity NPC469681
0.8828 High Similarity NPC471974
0.8828 High Similarity NPC469680
0.8816 High Similarity NPC144283
0.8792 High Similarity NPC160777
0.8792 High Similarity NPC73416
0.8784 High Similarity NPC239608
0.8784 High Similarity NPC46161
0.8776 High Similarity NPC472410
0.8776 High Similarity NPC84273
0.8741 High Similarity NPC327410
0.8716 High Similarity NPC11314
0.8693 High Similarity NPC124842
0.8667 High Similarity NPC225351
0.8636 High Similarity NPC164912
0.863 High Similarity NPC118366
0.8621 High Similarity NPC88065
0.8621 High Similarity NPC95485
0.8621 High Similarity NPC89504
0.8592 High Similarity NPC25736
0.859 High Similarity NPC471968
0.8581 High Similarity NPC82336
0.8581 High Similarity NPC62051
0.8581 High Similarity NPC78987
0.8571 High Similarity NPC118427
0.8571 High Similarity NPC478060
0.8571 High Similarity NPC470377
0.8571 High Similarity NPC473201
0.8571 High Similarity NPC471975
0.8571 High Similarity NPC470374
0.8571 High Similarity NPC478059
0.8571 High Similarity NPC302783
0.8544 High Similarity NPC185617
0.8542 High Similarity NPC50763
0.8533 High Similarity NPC46880
0.8531 High Similarity NPC66905
0.8506 High Similarity NPC473579
0.8506 High Similarity NPC475454
0.8506 High Similarity NPC475311
0.8506 High Similarity NPC473680
0.8506 High Similarity NPC58310
0.8506 High Similarity NPC295977
0.85 High Similarity NPC100420
0.8497 Intermediate Similarity NPC474903
0.8476 Intermediate Similarity NPC471969
0.8471 Intermediate Similarity NPC470762
0.8471 Intermediate Similarity NPC474167
0.8462 Intermediate Similarity NPC127172
0.8462 Intermediate Similarity NPC304622
0.8452 Intermediate Similarity NPC306011
0.8452 Intermediate Similarity NPC472838
0.8451 Intermediate Similarity NPC32163
0.8451 Intermediate Similarity NPC16651
0.8431 Intermediate Similarity NPC58373
0.8421 Intermediate Similarity NPC258856
0.8414 Intermediate Similarity NPC239302
0.8411 Intermediate Similarity NPC50954
0.8408 Intermediate Similarity NPC234485
0.8397 Intermediate Similarity NPC312338
0.8397 Intermediate Similarity NPC149889
0.8389 Intermediate Similarity NPC474784
0.8389 Intermediate Similarity NPC223336
0.8387 Intermediate Similarity NPC472279
0.8387 Intermediate Similarity NPC118033
0.8387 Intermediate Similarity NPC48949
0.8367 Intermediate Similarity NPC252343
0.8355 Intermediate Similarity NPC91694
0.8355 Intermediate Similarity NPC300603
0.8354 Intermediate Similarity NPC472803
0.8354 Intermediate Similarity NPC279605
0.8333 Intermediate Similarity NPC28398
0.8333 Intermediate Similarity NPC473773
0.8333 Intermediate Similarity NPC75377
0.8333 Intermediate Similarity NPC78505
0.8333 Intermediate Similarity NPC475579
0.8323 Intermediate Similarity NPC134293
0.8322 Intermediate Similarity NPC276466
0.8322 Intermediate Similarity NPC123722
0.8322 Intermediate Similarity NPC151167
0.8322 Intermediate Similarity NPC5018
0.8322 Intermediate Similarity NPC123228
0.8312 Intermediate Similarity NPC77598
0.8311 Intermediate Similarity NPC324929
0.8302 Intermediate Similarity NPC180011
0.8302 Intermediate Similarity NPC161960
0.8302 Intermediate Similarity NPC37543
0.8302 Intermediate Similarity NPC178976
0.8302 Intermediate Similarity NPC199463
0.8302 Intermediate Similarity NPC187745
0.8302 Intermediate Similarity NPC219867
0.8302 Intermediate Similarity NPC304008
0.8301 Intermediate Similarity NPC75295
0.8291 Intermediate Similarity NPC38898
0.8291 Intermediate Similarity NPC472048
0.8289 Intermediate Similarity NPC469615
0.8288 Intermediate Similarity NPC153453
0.8282 Intermediate Similarity NPC200726
0.8282 Intermediate Similarity NPC263212
0.828 Intermediate Similarity NPC474993
0.8276 Intermediate Similarity NPC172673
0.8269 Intermediate Similarity NPC475718
0.8261 Intermediate Similarity NPC472906
0.8258 Intermediate Similarity NPC55327
0.8255 Intermediate Similarity NPC471152
0.8252 Intermediate Similarity NPC127937
0.8252 Intermediate Similarity NPC84076
0.8252 Intermediate Similarity NPC179777
0.8252 Intermediate Similarity NPC303680
0.8252 Intermediate Similarity NPC92207
0.8252 Intermediate Similarity NPC90128
0.825 Intermediate Similarity NPC235448
0.8247 Intermediate Similarity NPC39361
0.8239 Intermediate Similarity NPC77807
0.8239 Intermediate Similarity NPC312404
0.8239 Intermediate Similarity NPC273686
0.8239 Intermediate Similarity NPC5379
0.8239 Intermediate Similarity NPC14561
0.8239 Intermediate Similarity NPC115853
0.8239 Intermediate Similarity NPC213401
0.8235 Intermediate Similarity NPC207732
0.8235 Intermediate Similarity NPC469683
0.8235 Intermediate Similarity NPC142165
0.8232 Intermediate Similarity NPC177362
0.8231 Intermediate Similarity NPC474715
0.8231 Intermediate Similarity NPC138472
0.8231 Intermediate Similarity NPC4170
0.8228 Intermediate Similarity NPC25127
0.8228 Intermediate Similarity NPC477047
0.8228 Intermediate Similarity NPC477048
0.8224 Intermediate Similarity NPC137920
0.8224 Intermediate Similarity NPC125134
0.8224 Intermediate Similarity NPC86455
0.8221 Intermediate Similarity NPC26386
0.8217 Intermediate Similarity NPC256406
0.8212 Intermediate Similarity NPC470035
0.821 Intermediate Similarity NPC149389
0.8205 Intermediate Similarity NPC69430
0.8205 Intermediate Similarity NPC264550
0.8205 Intermediate Similarity NPC264289
0.8205 Intermediate Similarity NPC139293
0.8205 Intermediate Similarity NPC195763
0.8205 Intermediate Similarity NPC142876
0.8205 Intermediate Similarity NPC200060
0.8205 Intermediate Similarity NPC261322
0.8205 Intermediate Similarity NPC40290
0.8205 Intermediate Similarity NPC333691
0.8205 Intermediate Similarity NPC37220
0.82 Intermediate Similarity NPC132723
0.82 Intermediate Similarity NPC325625
0.82 Intermediate Similarity NPC76032
0.8194 Intermediate Similarity NPC470757

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC237441 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8158 Intermediate Similarity NPD8166 Discontinued
0.8069 Intermediate Similarity NPD9494 Approved
0.8042 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7952 Intermediate Similarity NPD7473 Discontinued
0.7888 Intermediate Similarity NPD2801 Approved
0.7847 Intermediate Similarity NPD3972 Approved
0.7826 Intermediate Similarity NPD1934 Approved
0.7791 Intermediate Similarity NPD3882 Suspended
0.7778 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD6232 Discontinued
0.775 Intermediate Similarity NPD7458 Discontinued
0.7714 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7702 Intermediate Similarity NPD7028 Phase 2
0.7692 Intermediate Similarity NPD4628 Phase 3
0.7566 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD3620 Phase 2
0.7552 Intermediate Similarity NPD5536 Phase 2
0.7548 Intermediate Similarity NPD2935 Discontinued
0.7547 Intermediate Similarity NPD1511 Approved
0.7543 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD3534 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2344 Approved
0.75 Intermediate Similarity NPD8434 Phase 2
0.7485 Intermediate Similarity NPD3818 Discontinued
0.7484 Intermediate Similarity NPD2799 Discontinued
0.7471 Intermediate Similarity NPD6166 Phase 2
0.7471 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD7003 Approved
0.7455 Intermediate Similarity NPD7819 Suspended
0.7453 Intermediate Similarity NPD1512 Approved
0.7451 Intermediate Similarity NPD943 Approved
0.744 Intermediate Similarity NPD5494 Approved
0.7438 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD3226 Approved
0.7405 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD2798 Approved
0.7399 Intermediate Similarity NPD7074 Phase 3
0.7397 Intermediate Similarity NPD2932 Approved
0.7396 Intermediate Similarity NPD8127 Discontinued
0.7389 Intermediate Similarity NPD2346 Discontinued
0.7389 Intermediate Similarity NPD1471 Phase 3
0.7383 Intermediate Similarity NPD1876 Approved
0.7378 Intermediate Similarity NPD4380 Phase 2
0.7372 Intermediate Similarity NPD1510 Phase 2
0.7365 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD4110 Phase 3
0.7355 Intermediate Similarity NPD1607 Approved
0.7355 Intermediate Similarity NPD6651 Approved
0.7346 Intermediate Similarity NPD6273 Approved
0.7341 Intermediate Similarity NPD7054 Approved
0.7338 Intermediate Similarity NPD1240 Approved
0.7333 Intermediate Similarity NPD6873 Phase 2
0.7321 Intermediate Similarity NPD7075 Discontinued
0.7314 Intermediate Similarity NPD7685 Pre-registration
0.7312 Intermediate Similarity NPD2309 Approved
0.7305 Intermediate Similarity NPD3817 Phase 2
0.7305 Intermediate Similarity NPD5978 Approved
0.7305 Intermediate Similarity NPD5977 Approved
0.7301 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD7472 Approved
0.729 Intermediate Similarity NPD447 Suspended
0.7284 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7279 Intermediate Similarity NPD3019 Approved
0.7273 Intermediate Similarity NPD5283 Phase 1
0.7273 Intermediate Similarity NPD8032 Phase 2
0.7273 Intermediate Similarity NPD6599 Discontinued
0.7267 Intermediate Similarity NPD1283 Approved
0.7254 Intermediate Similarity NPD228 Approved
0.7246 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD1465 Phase 2
0.7241 Intermediate Similarity NPD5844 Phase 1
0.7233 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD1470 Approved
0.7215 Intermediate Similarity NPD6099 Approved
0.7215 Intermediate Similarity NPD6100 Approved
0.7211 Intermediate Similarity NPD1651 Approved
0.7188 Intermediate Similarity NPD2800 Approved
0.7179 Intermediate Similarity NPD230 Phase 1
0.7176 Intermediate Similarity NPD6234 Discontinued
0.7175 Intermediate Similarity NPD7808 Phase 3
0.7152 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7095 Approved
0.7143 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD7411 Suspended
0.7125 Intermediate Similarity NPD1549 Phase 2
0.7119 Intermediate Similarity NPD7251 Discontinued
0.711 Intermediate Similarity NPD3926 Phase 2
0.7108 Intermediate Similarity NPD824 Approved
0.7097 Intermediate Similarity NPD3268 Approved
0.7097 Intermediate Similarity NPD2313 Discontinued
0.7083 Intermediate Similarity NPD37 Approved
0.7079 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD2534 Approved
0.7073 Intermediate Similarity NPD2533 Approved
0.7073 Intermediate Similarity NPD2532 Approved
0.7073 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD1201 Approved
0.7067 Intermediate Similarity NPD1281 Approved
0.7063 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD6797 Phase 2
0.7062 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD3300 Phase 2
0.7049 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD8312 Approved
0.7039 Intermediate Similarity NPD8313 Approved
0.7037 Intermediate Similarity NPD3750 Approved
0.7032 Intermediate Similarity NPD3027 Phase 3
0.7024 Intermediate Similarity NPD6386 Approved
0.7024 Intermediate Similarity NPD6385 Approved
0.7018 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7017 Intermediate Similarity NPD8150 Discontinued
0.7012 Intermediate Similarity NPD6799 Approved
0.7007 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD4060 Phase 1
0.7 Intermediate Similarity NPD2796 Approved
0.6994 Remote Similarity NPD6959 Discontinued
0.6994 Remote Similarity NPD1247 Approved
0.6994 Remote Similarity NPD6190 Approved
0.6993 Remote Similarity NPD3021 Approved
0.6993 Remote Similarity NPD3022 Approved
0.6989 Remote Similarity NPD7228 Approved
0.6987 Remote Similarity NPD3764 Approved
0.6982 Remote Similarity NPD6801 Discontinued
0.698 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6962 Remote Similarity NPD6355 Discontinued
0.6962 Remote Similarity NPD1933 Approved
0.6959 Remote Similarity NPD4966 Approved
0.6959 Remote Similarity NPD4965 Approved
0.6959 Remote Similarity NPD7768 Phase 2
0.6959 Remote Similarity NPD4967 Phase 2
0.6949 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6943 Remote Similarity NPD6663 Approved
0.6941 Remote Similarity NPD5761 Phase 2
0.6941 Remote Similarity NPD5760 Phase 2
0.6937 Remote Similarity NPD3299 Clinical (unspecified phase)
0.6933 Remote Similarity NPD4626 Approved
0.6918 Remote Similarity NPD1241 Discontinued
0.6908 Remote Similarity NPD1608 Approved
0.6905 Remote Similarity NPD3455 Phase 2
0.6905 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6903 Remote Similarity NPD5736 Approved
0.6899 Remote Similarity NPD2979 Phase 3
0.6894 Remote Similarity NPD2438 Suspended
0.689 Remote Similarity NPD2354 Approved
0.6887 Remote Similarity NPD3023 Approved
0.6887 Remote Similarity NPD3026 Approved
0.6867 Remote Similarity NPD3024 Approved
0.6867 Remote Similarity NPD3025 Approved
0.6863 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6855 Remote Similarity NPD3657 Discovery
0.6855 Remote Similarity NPD5735 Approved
0.6842 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6839 Remote Similarity NPD4624 Approved
0.6833 Remote Similarity NPD6559 Discontinued
0.6824 Remote Similarity NPD7157 Approved
0.6824 Remote Similarity NPD7110 Phase 1
0.6824 Remote Similarity NPD7109 Clinical (unspecified phase)
0.6821 Remote Similarity NPD3749 Approved
0.6815 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6811 Remote Similarity NPD2488 Approved
0.6811 Remote Similarity NPD2490 Approved
0.6807 Remote Similarity NPD7390 Discontinued
0.6806 Remote Similarity NPD2491 Approved
0.6802 Remote Similarity NPD2296 Approved
0.68 Remote Similarity NPD9545 Approved
0.68 Remote Similarity NPD7199 Phase 2
0.6798 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6797 Remote Similarity NPD9269 Phase 2
0.6792 Remote Similarity NPD4140 Approved
0.679 Remote Similarity NPD5406 Approved
0.679 Remote Similarity NPD5405 Approved
0.679 Remote Similarity NPD5408 Approved
0.679 Remote Similarity NPD5404 Approved
0.6786 Remote Similarity NPD6662 Clinical (unspecified phase)
0.6784 Remote Similarity NPD7577 Discontinued
0.6782 Remote Similarity NPD919 Approved
0.6782 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6781 Remote Similarity NPD1609 Clinical (unspecified phase)
0.678 Remote Similarity NPD2898 Approved
0.6774 Remote Similarity NPD2797 Approved
0.6774 Remote Similarity NPD3266 Approved
0.6774 Remote Similarity NPD1203 Approved
0.6774 Remote Similarity NPD3267 Approved
0.6772 Remote Similarity NPD6798 Discontinued
0.6766 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6765 Remote Similarity NPD6875 Approved
0.6765 Remote Similarity NPD6876 Approved
0.6753 Remote Similarity NPD5327 Phase 3
0.6752 Remote Similarity NPD6832 Phase 2
0.6748 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6747 Remote Similarity NPD7236 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data